The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSophos Group Regulatory News (SOPH)

  • There is currently no data for SOPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SOPHOS GROUP PLC

6 Jan 2020 11:34

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)Full name of discloser:Barclays PLC.
 
(b)Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c)Name of offeror/offeree in relation to whoseSOPHOS GROUP PLC
relevant securities this form relates:
(d)If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e)Date position held/dealing undertaken:03 January 2020
(f)In addition to the company in 1(c) above, is the discloser makingNO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:3p ordinary
InterestsShort Positions
Number(%)Number(%)

(1)

Relevant securities owned

 

 

 

 

and/or controlled:

30,165,038

6.13%

13,747,696

2.79%

 

 

 

 

(2)

Cash-settled derivatives:

 

 

 

 

536,339

0.11%

28,590,308

5.81%

 

 

 

 

(3)

Stock-settled derivatives (including options)

 

 

 

 

and agreements to purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

TOTAL:

30,701,377

6.23%

42,338,004

8.60%

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevantPurchase/saleNumber ofPrice per unit
securitysecurities

3p ordinary

Purchase

87

5.6297 GBP

3p ordinary

Purchase

297

5.6240 GBP

3p ordinary

Purchase

1,175

5.6247 GBP

3p ordinary

Purchase

1,253

5.6200 GBP

3p ordinary

Purchase

1,273

5.6254 GBP

3p ordinary

Purchase

1,602

5.6220 GBP

3p ordinary

Purchase

2,334

5.6260 GBP

3p ordinary

Purchase

2,934

5.6189 GBP

3p ordinary

Purchase

4,263

5.6180 GBP

3p ordinary

Purchase

6,750

5.6182 GBP

3p ordinary

Purchase

8,000

5.6225 GBP

3p ordinary

Purchase

9,346

5.6231 GBP

3p ordinary

Purchase

10,459

5.6223 GBP

3p ordinary

Purchase

24,019

5.6314 GBP

3p ordinary

Sale

24

5.6322 GBP

3p ordinary

Sale

264

5.6160 GBP

3p ordinary

Sale

554

5.6260 GBP

3p ordinary

Sale

588

5.6235 GBP

3p ordinary

Sale

612

5.6200 GBP

3p ordinary

Sale

965

5.6220 GBP

3p ordinary

Sale

2,480

5.6234 GBP

3p ordinary

Sale

4,380

5.6320 GBP

3p ordinary

Sale

4,813

5.6122 GBP

3p ordinary

Sale

6,625

5.6151 GBP

3p ordinary

Sale

8,682

5.6241 GBP

3p ordinary

Sale

11,000

5.6232 GBP

3p ordinary

Sale

29,800

5.6245 GBP

3p ordinary

Sale

49,600

5.6267 GBP

(b) Cash-settled derivative transactions

Class ofProductNature of dealingNumber ofPrice per
relevantdescriptionreferenceunit
securitysecurities

3p ordinary

SWAP

Long

575

5.6320 GBP

3p ordinary

CFD

Long

588

5.6235 GBP

3p ordinary

SWAP

Long

1,070

5.6204 GBP

3p ordinary

SWAP

Long

1,339

5.6070 GBP

3p ordinary

SWAP

Long

2,904

5.6307 GBP

3p ordinary

SWAP

Long

3,557

5.6319 GBP

3p ordinary

CFD

Long

5,913

5.6191 GBP

3p ordinary

CFD

Long

6,625

5.6151 GBP

3p ordinary

SWAP

Long

9,939

5.6246 GBP

3p ordinary

SWAP

Long

10,675

5.6215 GBP

3p ordinary

SWAP

Long

17,210

5.6186 GBP

3p ordinary

SWAP

Long

19,861

5.6244 GBP

3p ordinary

SWAP

Short

154

5.6253 GBP

3p ordinary

SWAP

Short

5,256

5.6222 GBP

3p ordinary

SWAP

Short

8,000

5.6225 GBP

3p ordinary

SWAP

Short

9,431

5.6238 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:6 Jan 2020
Contact name:Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200106005466/en/

Copyright Business Wire 2020

Date   Source Headline
25th Feb 20201:11 pmRNSForm 8.3 -Sophos Group Plc
25th Feb 202011:37 amRNSForm 8.5 (EPT/RI)
25th Feb 202011:21 amBUSForm 8.3 - Sophos Group plc
25th Feb 202011:13 amRNSScheme of arrangement
25th Feb 202010:39 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
25th Feb 202010:38 amRNSForm 8.5 (EPT/NON-RI)- Sophos Group plc
25th Feb 202010:25 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
25th Feb 20208:32 amRNSRule 2.9 Announcement
24th Feb 20205:45 pmRNSSophos Group
24th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
24th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
24th Feb 20202:00 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc
24th Feb 20201:13 pmRNSForm 8.3 - Sophos Group Plc
24th Feb 202012:43 pmBUSForm 8.3 - Sophos Group plc
24th Feb 202011:47 amRNSForm 8.5 (EPT/RI)
24th Feb 202011:06 amRNSForm 8.5 (EPT/RI)Sophos Group plc
24th Feb 202010:52 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
21st Feb 20203:30 pmRNSForm 8.3 - SOPH LN
21st Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
21st Feb 20203:15 pmBUSFORM 8.3 - SOPHOS GROUP PLC
21st Feb 20202:42 pmRNSForm 8.3 - Sophos Group plc
21st Feb 20202:09 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc
21st Feb 202011:56 amRNSForm 8.3 - Sophos Group PLC
21st Feb 202011:28 amRNSForm 8.3 - Sophos Group Plc
21st Feb 202011:04 amRNSForm 8.5 (EPT/RI) - Sophos group plc
21st Feb 202011:04 amRNSForm 8.5 (EPT/RI)
21st Feb 202010:39 amBUSForm 8.3 - SOPHOS GROUP PLC
21st Feb 202010:28 amRNSForm 8.5 (EPT/RI) - Sophos Group plc
20th Feb 20205:30 pmRNSSophos Group
20th Feb 20203:42 pmRNSForm 8.3 - Sophos Group plc
20th Feb 20203:25 pmRNSForm 8.3 - Sophos Group PLC
20th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
20th Feb 20203:15 pmBUSForm 8.3 - Sophos Group plc
20th Feb 20201:12 pmBUSForm 8.3 - SOPH LN Equity 19-February-20 Decrease Traded Position
20th Feb 202012:54 pmRNSForm 8.3 - Sophos Group Plc
20th Feb 202012:03 pmRNSForm 8.3 - Sophos Group PLC
20th Feb 202011:20 amRNSForm 8.5 (EPT/RI)
20th Feb 202011:15 amRNSForm 8.5 (EPT/RI) - Sophos Group plc Replacement
20th Feb 202010:39 amRNSForm 8.5 (EPT/RI)- Sophos Group plc
20th Feb 202010:32 amBUSForm 8.3 - Sophos Group plc
20th Feb 202010:04 amRNSForm 8.3 - Sophos Group plc
19th Feb 20204:15 pmRNSForm 8.3 - Sophos Group plc
19th Feb 20203:20 pmRNSForm 8.3 - Sophos Group PLC
19th Feb 20203:18 pmBUSForm 8.3 - Sophos Group plc
19th Feb 20203:17 pmBUSForm 8.3 - SOPH LN Equity 18-February-20 Decrease Traded Position
19th Feb 20202:40 pmEQSForm 8.3 - The Vanguard Group, Inc.: Sophos Group plc
19th Feb 20201:19 pmRNSForm 8.3 - Sophos Group PLC
19th Feb 202012:18 pmBUSFORM 8.3 - SOPHOS GROUP PLC
19th Feb 202011:50 amRNSForm 8.5 (EPT/RI)
19th Feb 202011:31 amRNSForm 8.3 - Sophos Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.